1190-53-0 | Butyl-biguanidehydrochloride

Packsize	Purity	Availability	Price	Discounted Price
50mg	95%	in stock	$50.00	$35.00
250mg	95%	in stock	$201.00	$141.00

Description

• Catalog Number: AA32212
• Chemical Name: Butyl-biguanidehydrochloride
• CAS Number: 1190-53-0
• Molecular Formula: C6H16ClN5
• Molecular Weight: 193.6777
• MDL Number: MFCD00045591
• SMILES: CCCCNC(=N)NC(=N)N.Cl

Computed Properties

• Complexity: 156
• Covalently-Bonded Unit Count: 2
• Heavy Atom Count: 12
• Hydrogen Bond Acceptor Count: 1
• Hydrogen Bond Donor Count: 4
• Rotatable Bond Count: 4

Upstream Synthesis Route

Butyl-biguanide hydrochloride, also known as butylbiguanide hydrochloride or BBHC, is a chemical compound commonly used in chemical synthesis processes. This versatile compound is valued for its unique properties and diverse applications in various industrial and scientific fields.In chemical synthesis, Butyl-biguanide hydrochloride serves as a crucial reagent for the formation of complex organic molecules. Its ability to act as a strong nucleophile makes it particularly useful in nucleophilic addition reactions, where it can effectively attack electrophilic centers to form new bonds. This reactivity is key in the construction of pharmaceuticals, agrochemicals, and other fine chemicals.Additionally, Butyl-biguanide hydrochloride can function as a catalyst in certain reactions, accelerating the transformation of reactants into desired products. Its catalytic properties are exploited in the synthesis of heterocyclic compounds, polymerization processes, and other chemical transformations that benefit from its catalytic activity.Furthermore, Butyl-biguanide hydrochloride is employed as a precursor in the preparation of various derivatives with distinct functionalities. By modifying its structure through chemical derivatization, researchers can tailor its properties for specific applications, enhancing the efficiency and selectivity of synthetic routes.Overall, Butyl-biguanide hydrochloride plays a vital role in advancing chemical synthesis techniques, enabling the creation of intricate molecules with precision and control. Its versatility, reactivity, and catalytic capabilities make it a valuable asset in the realm of organic chemistry and synthetic methods.

Literature

• Biguanide-induced mitochondrial dysfunction yields increased lactate production and cytotoxicity of aerobically-poised HepG2 cells and human hepatocytes in vitro.

  Toxicology and applied pharmacology 20081201

• Determination of antihyperglycemic biguanides in serum and urine using an ion-pair solid-phase extraction technique followed by HPLC-UV on a pentafluorophenylpropyl column and on an octadecyl column.

  Biomedical chromatography : BMC 20061101

• Buformin suppresses the expression of glyceraldehyde 3-phosphate dehydrogenase.

  Biological & pharmaceutical bulletin 20060501

• Effect of buformin and metformin on formation of advanced glycation end products by methylglyoxal.

  Clinica chimica acta; international journal of clinical chemistry 20050801

• [A case of lactic acidosis caused by buformin in an oldest elderly diabetic patient].

  Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics 20050301

• [A new case of lactic acidosis caused by buformin].

  Anales de medicina interna (Madrid, Spain : 1984) 20050201

• Short-term effect of buformin, a biguanide, on insulin sensitivity, soluble fraction of tumor necrosis factor receptor and serum lipids in overweight patients with type 2 diabetes mellitus.

  Diabetes research and clinical practice 20041101

• Buformin-induced lactic acidosis--a symptom of modern healthcare malady.

  Journal of the American Geriatrics Society 20041001

• A validated HPLC method with ultraviolet detection for the determination of buformin in plasma.

  Biomedical chromatography : BMC 20040501

• Plasma BNP levels in the treatment of type 2 diabetes with pioglitazone.

  The Journal of clinical endocrinology and metabolism 20030801

• [Lactic acidosis associated with buformine use].

  Revista clinica espanola 20030401

• Insulin and longevity: antidiabetic biguanides as geroprotectors.

  Biogerontology 20030101

• Enhanced secretion of glucagon-like peptide 1 by biguanide compounds.

  Biochemical and biophysical research communications 20021115

• A new method for determination of buformin in plasma and urine by ion-paired reversed-phase HPLC with ultraviolet detection.

  Biomedical chromatography : BMC 20021001

• [Clinical usefulness of treatment with biguanide and insulin].

  Nihon rinsho. Japanese journal of clinical medicine 20020901

• Acrylic microspheres for oral controlled release of the biguanide buformin.

  International journal of pharmaceutics 20010507

• Buformin concentrations in a case of fatal lactic acidosis.

  Diabetologia 19810101

• [Lactic acidosis--a possible complication in buformin-treated diabetics (author's transl)].

  Klinische Wochenschrift 19780901